Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters (Q28396602)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters	scientific article

Statements

scholarly article

0 references

Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters (English)

0 references

1 reference

based on heuristic

inferred from title

Ignacio I Wistuba

15

object named as

Ignacio I Wistuba

0 references

18

object named as

John V Heymach

0 references

Wayne L. Hofstetter

3

object named as

Wayne L Hofstetter

0 references

Stephen Swisher

17

object named as

Stephen G Swisher

0 references

Arlene G Correa

10

object named as

Arlene M Correa

0 references

16

object named as

Jack A Roth

0 references

4

object named as

Yanbin Zhou

0 references

6

object named as

Chengcheng Guo

0 references

9

object named as

Apar Pataer

0 references

19

object named as

Bingliang Fang

0 references

13

object named as

Lixia Diao

0 references

author name string

Yong He

1

0 references

Zhen Zhou

2

0 references

Wenxian Hu

5

0 references

Li Wang

7

0 references

Wei Guo

8

0 references

Yiling Lu

11

0 references

Jing Wang

12

0 references

Lauren Averett Byers

14

0 references

language of work or name

0 references

publication date

2012

0 references

0 references

7

0 references

2

0 references

e31087

0 references

copyright license

Creative Commons Attribution 4.0 International

10 February 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Factors underlying sensitivity of cancers to small-molecule kinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

19 March 2017

The combined status of ATM and p53 link tumor development with therapeutic response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

19 March 2017

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

19 March 2017

A microRNA expression signature of human solid tumors defines cancer gene targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

19 March 2017

CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

19 March 2017

Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

19 March 2017

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

19 March 2017

Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

19 March 2017

A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

7 April 2017

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

7 April 2017

DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Inhibiting JNK dephosphorylation and induction of apoptosis by novel anticancer agent NSC-741909 in cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

An oncogene-induced DNA damage model for cancer development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Signal transducer and activator of transcription-5 activation and breast cancer prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Protein kinase inhibitors: insights into drug design from structure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Expression of Ku70 and Ku80 mediated by NF-kappa B and cyclooxygenase-2 is related to proliferation of human gastric cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Selective p38 activation in human non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277494

29 September 2017

Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031087

21 January 2018

Expression and heterodimer-binding activity of Ku70 and Ku80 in human non-melanoma skin cancer

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031087

21 January 2018

Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031087

21 January 2018

Non-parametric quantification of protein lysate arrays

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0031087

21 January 2018

Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array

1 reference

https://pubmed.ncbi.nlm.nih.gov/22348039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22348039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22348039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0031087

0 references

2012PLoSO...731087H

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28396602&oldid=2261819560"